Skip to main content

Series B Life Science Companies

Explore 128 life science startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
128
Total Funding
$3.5B
Avg Funding
$138.7M
Cities
15

Export 128 Series B Life Science Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
$6.2M
raised

AceRNA Technologies is a biotech startup that develops patient-centric genetic therapies with RNA switch technology for drug discovery.

May 2024
Series B

Founder Contacts

30,000+ verified contacts

San Francisco, United States
$40.0M
raised

Curebase is the modern eClinical platform for faster study builds, better engagement, and seamless data capture.

May 2022
Series B

Founder Contacts

30,000+ verified contacts

Basel, Switzerland
$165.0M
raised

Windward Bio develops monoclonal antibodies for advanced immunological diseases.

May 2026
Series B

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$122.0M
raised

CREATE Medicines is a biotech company developing in vivo CAR therapies using mRNA-LNP immune cell programming technology.

May 2026
Series B

Founder Contacts

30,000+ verified contacts

New Haven, United States
$26.5M
raised

Allyx Therapeutics is a clinical-stage biotechnology company that develops therapies to reverse neurodegeneration.

May 2026
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 128 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
London, United Kingdom
$2.1B
raised

Isomorphic Labs is an AI-first drug design and development company that transforms drug discovery to design and evaluate new medicines.

May 2026
Series B

Founder Contacts

30,000+ verified contacts

San Diego, United States
$137.0M
raised

Sidewinder Therapeutics is a biotechnology company that offers life-saving therapies for cancer and rare diseases.

Apr 2026
Series B

Founder Contacts

30,000+ verified contacts

Cambridge, United States

Kytopen develops genome engineering platforms that enable cell therapy research and manufacturing.

Apr 2026
Series B

Founder Contacts

30,000+ verified contacts

Los Angeles, United States
$80.0M
raised

Octant Bio is a developer of synthetic technology used to improve health and treat disease.

Apr 2022
Series B

Founder Contacts

30,000+ verified contacts

San Francisco, United States

Stämm is transforming biomanufacturing with nature-inspired, scalable, and sustainable solutions.

Apr 2023
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 128 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Boston, United States

Profility offers support and training, process analysis, and software support description services, including requirements analysis.

Apr 2023
Series B

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$40.0M
raised

Atavistik Bio is a biotechnology company that develops precision allosteric small molecules aimed at treating metabolic diseases and cancer.

Mar 2026
Series B

Founder Contacts

30,000+ verified contacts

San Jose, United States
$40.0M
raised

Advancing Clinical Research by Combining Machine Precision and Human Intuition

Mar 2022
Series B

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$123.0M
raised

Flare Therapeutics is a biotech startup that creates precision therapies for cancer and other disorders by targeting transcription factors.

Mar 2023
Series B

Founder Contacts

30,000+ verified contacts

Hayward, United States
$36.5M
raised

Spotlight Therapeutics is a biotechnology company that develops biologics targeted to specific cell populations in gene editing.

Mar 2022
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 128 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
San Diego, United States
$45.2M
raised

Empirico is a developer of an insights platform designed to turn biological insights from human genetics into new medicines.

Mar 2023
Series B

Founder Contacts

30,000+ verified contacts

San Diego, United States
$167.0M
raised

Engrail Therapeutics is a developer of medicines to transform the lives of patients with life-limiting diseases of the nervous system.

Mar 2024
Series B

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$77.0M
raised

Crossbow Therapeutics is a biotech company that develops targeted therapies to address cancer antigens.

Mar 2026
Series B

Founder Contacts

30,000+ verified contacts

Santa Cruz, United States
$45.0M
raised

Unnatural Products is a biotech company that focuses on unlocking macrocyclic peptides to create drug therapies.

Mar 2026
Series B

Founder Contacts

30,000+ verified contacts

Torino, Italy
$20.4M
raised

Kither Biotech is a pharmaceutical product company that developmens of new drugs to treat chronic inflammatory diseases

Mar 2022
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 128 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
San Francisco, United States
$40.0M
raised

IgGenix is a biotechnology company.

Feb 2023
Series B

Founder Contacts

30,000+ verified contacts

College Park, United States
$75.0M
raised

Altesa is a clinical-stage biopharmaceutical company dedicated to accelerating the development of new treatments

Feb 2026
Series B

Founder Contacts

30,000+ verified contacts

San Francisco, United States
$8.3M
raised

Chronicled builds trust and automation in the life science industry, powered by blockchain.

Feb 2022
Series B

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$42.5M
raised

NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.

Feb 2024
Series B

Founder Contacts

30,000+ verified contacts

Carmel, United States
$30.0M
raised

Sudo Biosciences is a biopharma company that designs and develops medicines that target the tyrosine kinase 2 (TYK2) pseudokinase domain.

Feb 2024
Series B

Founder Contacts

30,000+ verified contacts

Showing 26 to 50 of 128 companies

Ready to Connect with Series B Life Science Startups?

Get verified founder emails, funding details, and company data for 128 series b life science companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked